Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth 15 Oct Written By Alexandra Collingbourne Alexandra Collingbourne
Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth 15 Oct Written By Alexandra Collingbourne Alexandra Collingbourne
